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ABSTRACT 
 
Isoprenoids are naturally produced compounds in the budding yeast Saccharomyces 
cerevisiae.  They are involved in essential cellular functions of the cell and are also 
further synthesized into pharmaceuticals, carotenoids, and biofuel alternatives. S. 
cerevisiae is a key model eukaryotic organism because it is both tractable and a 
nonpathogenic GRAS organism (Generally Recognized As Safe). S. cerevisiae is used 
extensively in metabolic engineering due to its well-curated and annotated genome and 
the wide range of tools available for genetic modifications. Engineering S. cerevisiae for 
production of heterologous isoprenoid compounds is a sustainable and cost effective 
alternate to production via chemical synthesis.  β-carotene, an abundant isoprenoid 
compound in nature, protects cells from oxidative stress and reactive oxidative species in 
the environment. Through a novel adaptive evolution experiment of S. cerevisiae with 
oxidative stress as the driving force, we obtained a carotenoid hyper-producer strain that 
is able to produce 18 ± 1 mg/g [dry cell weight] β-carotene in 3 ml cultures. To test the 
potential for scale-up β-carotene production in yeast, we fermented the cultures in a 7L 
bioreactor. Optimization of the bioreactor parameters revealed the influence of media 
composition, aeration, and pH on β-carotene production.  
 
We aimed to further optimize β-carotene production in S. cerevisiae with genetic and 
metabolic engineering.  We reintroduced the cytosolic catalase T (CTT1) gene and 
overexpressed the known bottleneck of the isoprenoid biosynthesis pathway, HMG1. 
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The reintroduction of CTT1 into SM14 (carotenoid hyper-producer) demonstrated 
improvement in carotenoid production, where production increased from 15 ± 3.3 mg/g 
[dry cell weight] to 22 ± 2.1 mg/g [dry cell weight]. The overexpression of truncated 
HMG1 in SM14, on the other hand, did not increase β-carotene production.  The 
isoprenoid pathway is of a very complex phenotype and there are many direct and 
indirect variables involved in pathway performance. Even with these modifications to 
the hyper-producer strain, there seems to be limitations on β-carotene production.  
Further studies currently under investigation to increase β-carotene production include 
utilizing the fatty acid β-oxidation pathway for increasing the fatty acid content of the 
cell. 
 
 
 
. 
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1. INTRODUCTION 
 
The synthesis of natural compounds by microbial systems is an emerging field in 
metabolic engineering for the application towards industrial biotechnology and 
production. There are many advantages of microbial-based compound production over 
the chemical synthesis or extraction of compounds including lower toxic waste 
production, carbon dioxide emissions, and energy requirements, as well as simpler 
purification processes, the potential for use of renewable feed stocks such as corn or 
soybeans, and the ability of enzymes to perform chiral synthesis on molecules [1].  
Many natural products, such as active pharmaceutical ingredients (APIs), are not feasible 
for chemical synthesis due to structural complexities and are only able to be produced 
through a cellular means. These compounds have a high market value such that there is a 
desire to produce them in a heterologous host and reap the benefits. Pharmaceutical 
compounds may be the most valuable and have the highest profit margins, but fine 
chemicals and molecules such as vitamins, fragrances, and organic acids are also capable 
of being biologically synthesized. Currently, many precursors for known APIs and fine 
chemicals are successfully being engineered into microbe hosts, which is the next step 
towards tailoring the cell to produce specific compounds [2]. The different types of 
molecules and compounds that can be created through metabolic engineering are only 
beginning to be discovered and there is a potential for break-through product formations. 
Engineered microbial catalysts are becoming the new generation method for a 
sustainable and economical route to produce desired compounds.   
 
Microbial systems that have been explored as heterologous production hosts include 
Escherichia coli and yeast [3-10].  The budding yeast Saccharomyces cerevisiae is the 
key model eukaryotic organism used extensively for metabolic engineering due to its 
well-studied genome and wide range of tools available for genetic modifications [1]. 
These two aspects make S. cerevisiae a great candidate as a biocatalyst for microbial 
production of natural products. S. cerevisiae is also favored for industrial processes due 
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to several factors such as its inherent robustness to high osmotic pressure and low pH, 
both of which are frequently encountered during industrial fermentation [2]. Yeast is 
also an economical organism to use because it grows quickly and at a low startup cost, 
which allows for high production throughput and quick turnaround time between 
batches.  
 
So far, metabolic engineering has converted this microbe into a potential “cell factory” 
for production of a diverse range of chemical compounds [11]. There is continuous work 
being done to genetically control yeast to “debottleneck” the desired pathways and 
maximize desired product titer, yield, and productivity [2]. Isoprenoids, for example, are 
a class of compounds with the potential for microbial-based production. Isoprenoids are 
a diverse group of over 30,000 identified compounds in nature [12-14].  They are 
essential for proper cellular function, but they also have industrial value as 
pharmaceuticals (e.g. taxol, artemisinin), pesticides, and nutriceuticals (e.g. carotenoids) 
[15]. The majority of isoprenoid compounds are components of essential oils that occur 
naturally in plants, but they also function as defensive agents against pathogens, 
reproductive hormones, mating pheromones, pigments, constituents of membranes, and 
components of signal transductions pathways [13]. There are two known pathways for 
isoprenoid biosynthesis in nature: the mevalonate-independent methyl erythritol 4-
phosphate (MEP) pathway and the mevalonate (MVA) pathway. In the MEP pathway, 
pyruvate and glyceraldehyde-3-phosphate (G3P) are synthesized into 1-deoxy-D-
xylulose-5-phosphate (DXP) that is then used to produce MEP.  The MVA pathway, 
most common in eukaryotes and the one utilized in S. cerevisiae, uses acetyl-CoA as the 
precursor to produce isopentenyl diphosphate (IPP) for mevalonate production [16].  The 
MVA pathway provides a promising route for the production of various natural 
compounds biosynthesized from the pathway precursors isopentenyl diphosphate (IPP) 
and dimethylallyl pyrophosphate (DMAPP).   
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Our goal is to focus on the integration and implementation of metabolic engineering 
tools in order to improve the productivity of yeast for maximum isoprenoid production. 
Current approaches generally focus on optimizing gene expressions and enzyme 
activities for the biosynthetic genes; however, genes outside the direct biosynthetic 
pathway of the target compound may play a role in productivity.  Indeed, prior studies 
have revealed the complex phenotype of isoprenoid biosynthesis in microorganisms. For 
example, in a pre-engineered E. coli strain, a combination of gene deletions in the 
genome increased lycopene production [17]. These genes were found by model-based 
and transposon-based approaches. Some of the genes found were outside of the direct 
isoprenoid biosynthesis pathway and they increased the supply of precursors and 
cofactors that are important in the lycopene biosynthesis pathway. Even with the gene 
deletions, the lycopene production was still below the predetermined stoichiometric 
maximum. This demonstrated that there are still unknown limiting kinetic and regulatory 
factors that are not accounted for in the stoichiometric model and that the isoprenoid 
pathway does not have a completely linear relationship [17].  
 
Previously, our lab developed a novel directed evolution approach to optimize the 
isoprenoid pathway in S. cerevisiae.  Increasing oxidative stress has been shown to 
increase β-carotene production in S. cerevisiae [18], so the hypothesis was that oxidative 
stress can be used as a driving force for directed evolution to enhance carotenoids 
production. We integrated a heterologous carotenoid gene cassette crt YB/I/E from the 
red yeast Xanthophyllomyces dendrorhous into S. cerevisiae and used adaptive evolution 
with hydrogen peroxide stress as the selective pressure to select for carotenoid hyper-
producers. The cytosolic catalase gene CTT1 was deleted from the genome to allow for 
more efficient hydrogen peroxide shocking experiments because CTT1 mediates the 
oxidative stress response in yeast. We reached more than 12 mg/g dry cell weight [dcw] 
of β-carotene shortly after the start of the evolution experiments. This was a 100% 
improvement over the unevolved ancestral strain, which had a β-carotene production of 
6 mg/g [dcw]. After the population evolution, single mutants were isolated from each 
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shock time point.  Hyper-producers were selected on the basis of growth (normal colony 
size) and increased carotenoid production in comparison to the population levels. Mutant 
SM14 was one of the highest producers that produced approximately 300% more β-
carotene (18 ± 1 mg/g [dcw]) over the ancestral strain (6 ± 1 mg/g [dcw]).  
 
My work has two primary goals, both of which aim to further optimize carotenoid 
production in S. cerevisiae. First, I will optimize the bioreactor conditions for carotenoid 
productivity in the hyper-producing mutant strain SM14.  My first goal is achieved with 
the following objectives: 1) determine the influence of pH, agitation, bioreactor batch 
run time, and medium on carotenoid production, and 2) perform bioreactor metabolite 
analysis for understanding the influence of growth kinetics and cell metabolite 
consumption on carotenoid production. Second, I will test the hypothesis that the β-
carotene production in the evolved mutant SM14 is limited by fatty acid content of the 
cell. To achieve my second goal, I will pursue the following objectives: 1) use rational 
metabolic engineering to improve carotenoid production (we expect an increase in the 
ancestral unevolved strain, but limited improvements in the evolved mutant) and 2) 
metabolic engineering to increase the fatty acid content of the cell. 
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2. BACKGROUND AND LITERATURE REVIEW 
 
2.1 Isoprenoid biosynthesis pathway 
Isoprenoids, also called terpenoids, are the largest class of naturally occurring molecules. 
The biosynthesis pathway for isoprenoid compounds has been highly conserved 
throughout evolution [19]. Plants have maintained the eukaryotic mevalonic acid (MVA) 
pathway in the cytosol, while evolving the methylerythritol phosphate (MEP) pathway 
from the endosymbiotic plastid ancestor [14]. Being that they are some of the most 
ancient molecules ever identified, isoprenoids and their derivatives have substantial roles 
in many life forms that include regulators of gene expression, reproductive hormones, 
components of membranes, vitamins, and antimicrobial agents [13, 19].  
 
The isoprenoid pathway in yeast begins with acetyl-CoA, which is the product of acetate 
metabolism. Acetyl-CoA is also responsible for initiating the TCA cycle and is a 
precursor to the synthesis of lipids, several amino acids, and histone acetylation [20]. 
Acetyl-CoA synthetase (ACS) catalyzes the reaction of acetate to acetyl-CoA. ACS-2 is 
considered the aerobic version of the enzyme and is not detected under anaerobic 
conditions. ACS-1 is induced under fermentation conditions. Acetyl Co-A is 
metabolized by ERG10 and ERG13 into HMG-CoA.  HMG-CoA is converted to 
mevalonate via the NADPH-requiring enzyme HMG-CoA reductase (HMGR), which is 
the rate-limiting step of the pathway [21-23]. The initial synthesis for isoprenoid 
compounds starts from two basic five carbon units, isopentenyl pyrophosphate (IPP) and 
dimethylallyl pyrophosphate (DMAPP) [24]. These carbon units are isomers of each 
other and are the building blocks for any isoprenoid compounds. Both isomers are 
capable of being further metabolized into geranyl diphosphate (GPP), farnesyl 
diphosphate (FPP), and geranylgeranyl diphosphate (GGPP), as seen in Figure 1 [1]. 
Naturally occurring precursors then convert these compounds into monoterpenes, 
sesquiterpenes, and diterpenes, respectively. 
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Figure 1. Biosynthesis of isoprenoids by the mevalonate pathway [1].  
 
In the budding yeast S. cerevisiae, the isoprenoid pathway is responsible for the 
production of essential molecules such as prenylated proteins, polyprenyl alcohols, heme 
A, ubiquitone, and sterols. Prenylated proteins are proteins that have a farnesyl (C15) or 
geranylgeranyl (C20) isoprenoid covalently linked to the conserved cysteine residues or 
at the C-terminus of proteins [25]. Studies have shown that the Ras proteins, which are 
small G-proteins that play crucial roles in the signaling pathways controlling cell growth 
and differentiation, are farnesylated [25].The other isoprenoid geranylgeranyl is the 
predominant compound found on cellular proteins [25]. Polyprenyl alcohols are 
ubiquitous in minor components of membranes in yeast. They are synthesized from 
DMAPP and IPP and then used for protein N-glycosylation [26]. Ubiquitone (also 
known as coenzyme Q or CoQ) has ten isoprene units and is an isoprenylated 
benzoquinone. CoQ is a well-known component of the electron transport chain, and its 
main role is to transfer electrons from NADH dehydrogenase and succinate 
dehydrogenase to the CoQ:cytochrome c reductase in aerobic respiration and oxidative 
phosphorylation in the mitochondrial respiratory chain. CoQ also contributes 
significantly to ATP synthesis and acts as a lipid-soluble antioxidant in cellular 
membranes that scavenges for reactive oxygen species [27].  Ergosterol is an end 
product of the MVA pathway in S. cerevisiae and is the most prominent sterol in the 
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plasma membrane. Sterols are essential components of the plasma membrane in yeast 
and are used for intracellular endocytosis. Sterols are also important for protection 
against oxidative stress. Genome-wide expression analysis in yeast has identified a 
strong relationship of genes involved in ergosterol biosynthesis and oxidative stress 
protection [28]. Two areas in the cell with the highest concentration of sterols are the 
plasma membrane and secretory vesicles [29]. The cell would not be able to function 
properly without any of these products from the isoprenoid pathway.  
 
2.2 Oxidative stress response in yeast 
Yeast depends on oxygen for survival and aerobic respiration; however, they have had to 
evolve a multitude of defense systems to protect themselves from oxygen’s toxic 
properties to the cell [30]. The extracellular environment of yeast is highly oxidative, 
providing for the need to maintain a reduced intracellular atmosphere. The reduced 
atmosphere is needed for proper protein formation and maintaining protein function 
[31]. Yeast cells generate a range of reactive oxidative species (ROS), which are usually 
the result of their aerobic metabolism but can also stem from environmental stress 
triggers [30, 32]. Known ROS that cause an inducible stress response are hydrogen 
peroxide, superoxide anion, and lipid peroxidation products [33]. Environmental stress 
triggers include the depletion of nutrients, increases in ambient temperature, or sudden 
xenobiotic contamination. Environmental changes invariably cause some stress on the 
cell, and this stress is frequently associated with ROS, which consume the antioxidants 
in the cell or further induce ROS accumulation [30].  
 
Accumulation of ROS results in oxidative damage to crucial biomolecules such as 
proteins, DNA, and lipids. The accumulation of oxidized proteins has been associated 
with cellular aging and compromises cell viability. The result of protein oxidation is the 
formation of protein carbonyls, which can form large protein aggregates that cannot be 
degraded by proteolytic mechanisms. Non-degraded large protein aggregates eventually 
disrupt cell homeostasis completely [30]. ROS has the ability to cause mistranslation of 
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mRNA (for dysfunctional protein synthesis), and can also target the actin cytoskeleton of 
yeast (this results in accelerated aging and cell apoptosis). Oxidative DNA damage can 
result in base modification, abasic sites, protein-DNA cross linkage, and single or double 
stranded breaks in DNA. Oxidized DNA then interferes with the normal response to 
oxidative stress, which causes further ROS accumulation and programmed cell death 
(PCD). Lipid peroxidation is often the result of lipid oxidative damage and is initiated by 
the oxidation of polyunsaturated fatty acids (PUFAs) into lipid hydroperoxides, by OH• 
radicals. S. cerevisiae produces saturated and monosaturated fatty acids of 16- and 18-
carbon atoms and PUFAs of no more than two double bonds [34]. Most yeast are not 
capable of synthesizing long chain PUFAs, but will readily incorporate them into their 
membranes if cultured with PUFA rich medium. This further increases the risk of 
oxidative stress to the cell [30].  
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Figure 2. Cellular responses to oxidative stress in Saccharomyces cerevisiae. Oxidative 
stress can result in either cell survival (shown in green) or cell death (shown in red). 
ROS can activate enzymatic (catalases) and non-enzymatic antioxidants (such as GSH). 
These response systems work together with the targeted removal of small, oxidized 
proteins by the ubiquitin-dependent proteasome system (UPS) to keep cells alive. Cells 
can activate cytoprotective autophagic pathways (yellow) that remove irreparable 
oxidized macromolecules or dysfunctional organelles, such as mitochondria. An 
abnormally high degree of autophagy will result in programmed cell death (PCD). If the 
cell is exposed to severe oxidants, lethal response pathways such as apoptosis and 
necrosis will be activated [30]. 
 
 
 10 
 
There are both non-enzymatic and enzymatic stress responses in yeast, as seen in Figure 
2 [30]. Non-enzymatic defense systems include but are not limited to the tripeptide 
glutathione (GSH), polyamides, lipid-soluble antioxidants, trehalose, metallothioneins, 
and glutaredoxin [33]. A study showed that glutathione deficient mutants are 
hypersensitive to H2O2 and also exhibit a slower growth rate and a longer lag phase than 
typical wild type cells. Glutathione has also been linked with protecting mitochondria 
from oxidants in the aerobic respiratory chain process [33]. Lipid soluble antioxidant 
molecules in yeast are also important for resistance to ROS. Cells with membranes 
containing higher amounts of saturated fatty acids are more resistant to oxidation effects 
than those cells with a higher concentration of PUFAs [33]. Autoxidation of PUFAs is a 
natural consequence of an oxygen rich environment and the lipid peroxidation products 
deteriorate membrane fluidity and cause oxidative damage to other biomolecules [35].  
 
Enzymatic stress responses in yeast include catalase genes, pentose phosphate pathway 
enzymes, glutathione reductase and peroxidase, thioredoxin peroxidase and reductase, 
and the methionine reductase.  The catalase genes CTA1 and CTT1 in S. cerevisiae play 
a role as peroxide scavengers and are responsible for the breakdown of H2O2 into O2 and 
H2O. H2O2 is a product of the fatty acid β-oxidation pathway and both catalase genes 
help in resistance towards H2O2 [33]. Cytosolic catalase T (CTT1) gene in S. cerevisiae 
has shown to be regulated by the supply of essential nutrients around the cell. Expression 
levels of CTT1 are low when grown in rich and complete media, but if any of the 
essential nutrients become limiting, expression levels rise substantially [36]. 
Overexpression of the CTT1 gene in S. cerevisiae has been shown to reduce overall ROS 
levels in the cell, which further helps maintain a normal amount of fatty acids in the cell 
[37]. The pentose phosphate metabolic pathway, which also aids in ROS protection in 
cells, produces nucleotides, antioxidants, and some lipids. The pathway includes glucose 
6-phosphate dehydrogenase (ZWF1), transketolase (TKL1) and ribulose 5-phosphate 
epimerase (RPE1). All are involved in cellular reduction via the production of NADPH, 
which promotes more antioxidant presence that results in increased tolerance to H2O2 
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stress. Glutathione and thioredoxin are both powerful antioxidants. The glutathione 
reductase maintains a high ratio of reduced to oxidized components in the cell and 
glutathione peroxidase catalyzes the reduction of hydroperoxides via GSH as a 
reductant. Thioredoxin peroxidase works in conjunction with thioredoxin reductase to 
reduce both H2O2 and alpha hyperperoxides inside the cell [33]. 
 
2.3 The role of carotenoids 
Carotenoids are naturally occurring terpenoid compounds of various pigments and serve 
many roles in microorganisms.  They have the ability to protect cells against various 
ROS by catalytically quenching singlet oxygen species (O2) that are generated from 
cellular metabolism. Carotenoids are present in both photosynthetic and non-
photosynthetic organisms, where they carry very diverse functional roles. In 
nonphotosynthetic organisms, one of the main functions is to isolate toxic oxygen 
species from the environment [38]. Carotenoids also increase membrane rigidity to help 
reduce the penetration of singlet oxygen species from the extracellular environment [39]. 
 
Carotenoids consist of a polyene chain of conjugated bonds with varying amounts of 
isoprene units. They are responsible for the different pigmentations seen in nature that 
absorb at a wavelength from 300 to 600 nm. The absorbance of the molecule is 
correlated to the number of conjugated bonds and functional groups. Two broad 
classifications of carotenoids include hydrocarbons (carotenes) and oxygenated 
derivatives (xanthophylls). Phytoene (C40H56) is a symmetrical acyclic C40 hydrocarbon 
structure that is formed by the condensation of two geranylgeranyl diphosphate (GGPP) 
molecules. It is the initial “colorless” carotenoid from which other carotenoid 
compounds are derived via various biochemical reactions. This group consists of about 
600 natural carotenoids and are mostly formed by enzyme mediated reactions [38]. 
Important carotenoids produced from microorganisms include β-Carotene, α-Carotene, 
β-Cryptoxanthin, Lutein, Zeaxanthin, Astaxanthin, Canthaxanthin, Neoxanthin, 
Violaxanthin, Antheraxanthin, and Fucoxanthin, as seen in Figure 3 [39].  
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Figure 3. Carotenoid biosynthesis pathway [1]. 
 
The evolutionary origins of carotenoids are thought to be from ancient anoxygenic 
photosynthetic microorganisms, long before the time of eukaryotes.  The phylum of 
bacteria known as cyanobacteria is the earliest record of oxygenic carotenoid producing 
bacteria that dates back 3.5 billion years with fossil and molecular evidence. Through 
microbe evolution, the carotenoid biosynthetic pathways diversified, which resulted in 
different structural forms of carotenoid molecules. The earths transition from an 
anaerobic to aerobic environment also impacted carotenoid diversity and their 
dependence on oxygen-dependent enzymes [39]. Carotenoids are believed to have 
evolved similar to sterols, which evolved in parallel to the appearance of atmospheric 
oxygen [38]. Eukaryotes then acquired the mechanism for carotenoid production either 
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by symbiotic growth with bacteria or via eukaryotic chloroplasts [38]. Prochlorophytes, 
which is another group of oxygenic photosynthetic bacteria, have similarities in 
carotenoid pigments to that of algae and eukaryotic plants. This also suggests crossover 
of evolutionary relations between species [39].  
 
Carotenoids form a unique medicinal and biotechnological class of natural pigments. 
They are structurally very diverse and are involved in many biological functions such as 
species coloration, photo protection, light harvesting, and are precursors to many 
hormones. Commercially, carotenoids are used in pharmaceuticals, cosmetics, food 
colorants, and in animal feed supplements [40]. The health benefits of carotenoids are 
becoming increasingly more understood. Carotenoids are not synthesized in animals, but 
act as pro-vitamin A compounds and can be metabolized into vitamin A and retinoids as 
a nutrition source.  Studies have shown that carotenoid compounds also exhibit disease-
fighting power and are able to prevent or slow down the presence of cancer or other 
chronic diseases such as multiple sclerosis, cataracts and arteriosclerosis [38].  
 
The market for carotenoid supplements is large and constantly growing. As of 2010, 
commercially used carotenoids had a value at nearly $1.2 billion with a projected value 
of $1.4 billion by 2018. Of that total value, β-carotene had a market value of $261 
million in 2010, which is roughly 20 percent of the total carotenoid value [41].  The 
majority of carotenoids on the global market are chemically synthesized or extracted via 
solvents from non-microbial sources [39]. In lieu of non-organic means of obtaining 
carotenoids, there are few viable options for microbe-based carotenoids that give 
competition to the chemically synthesized molecules. There is a growing consumer 
preference for natural additive supplements and an economical preference for production 
of carotenoids in microbes because of a potentially lower production cost [39]. 
Currently, the most commonly used microbes for natural carotenoid synthesis are 
Dunaliella salina for β-carotene and Haematococcus pluvialis or X. dendrorhous for 
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astaxanthin [42]. Further research is still needed to develop more technologies and to 
metabolically engineer other organisms to produce carotenoids.  
In general, factors affecting carotenoid production in microorganisms include light, 
temperature, chemical compounds, metals ions and salts, and solvents [42]. In the 
organism X. dendrorhous, astaxanthin production is proposed to be photo-inducible 
because an increase of carotenoid production is observed when exposed to strong light 
illumination. Reactive oxygen species are also seen as active participants and linked to 
improvements in carotenoid production [18, 42]. Temperature influences the growth and 
development of living organisms. It has the potential to alter the activity and 
concentrations of the enzymes involved in biosynthetic pathways, which reflects the 
activity of the isoprenoid production pathways. Across microorganisms, a lower 
temperature generally promotes a higher rate of carotenoid production. The hypothesis 
behind this phenomenon is that as temperature decreases, the membrane fluidity and 
functionality also decrease. This decrease in fitness is then compensated in the cell by 
overproduction of carotenoids and unsaturated lipids [42].  
 
To further understand the carotenogenic biosynthesis pathway in various organisms, 
researchers have explored chemical compounds and their impact on the pathway. For 
example, in the fungi species Blakeslea trispora, when penicillin (1 mg/L) was added to 
the culture after 24 hours of growth, carotenogenesis was stimulated by 50 percent 
without disrupting the total protein and carbohydrate synthesis. Authors suggested that 
penicillin stimulates the early stages of the isoprenoid pathway because mevalonate 
kinase was close to double in concentration under the presence of penicillin [42]. 
Similarly in Rhodotorula mucilaginosa, which is a unicellular pigmented yeast, 
chloramphenicol (1,000 mg/L) had a positive effect on total carotenoid production [42]. 
The yeast genus Rhodotorula also demonstrated an improvement of carotenoid 
volumetric production (mg/L) and yield when exposed to calcium, copper, zinc, and 
ferrous ions in the growth medium. The explained rationale behind this behavior is that 
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there is either a stimulation of carotenoid-synthesizing enzymes from the cations or that 
there is an increase in active oxygen free radicals in the surrounding medium [42].  
 
Solvents in the extracellular environment may also affect carotenoid production in 
microorganisms. The addition of ethanol, methanol, isopropanol, and ethylene glycol to 
the culture medium has been shown to help increase carotenoid production in microbes. 
When 2% (v/v) ethanol was added to the culture of Rhodotorula, there was a reported 
increase in β-carotene and a decrease in torulene. Torulene is a hydrocarbon carotenoid 
compound with only one cyclic end (versus two cyclic ends in β-carotene) [43]. It has 
been proposed that there is ethanol-mediated inhibition of torulene oxidation, which 
suggests that the there is a metabolic pathway shift to favor ring closure (as seen in β-
carotene). There was also a similar phenomenon seen in the red yeast X. dendrorhous 
(Phaffia rhodozyma) when 0.2% (v/v) ethanol was added to the culture medium [43]. 
Further detailed studies then indicated that ethanol activates oxidative metabolism with 
the induction of HMG-CoA reductase. HMG-CoA reductase is a key enzyme in the 
isoprenoid biosynthesis pathway. The activation of this enzyme naturally results in 
enhanced carotenoid production [43].  
 
The study of the natural red yeast X. dendrorhous has provided more knowledge about 
the factors affecting carotenoid yield. Additives to culture medium such as ethanol, 
acetate, and mevalonate have all resulted in an increase of carotenoid formation; 
however, any supplement such as mevalonate is not economically feasible for long-term 
industrial production. When X. dendrorhous is grown with additional ethanol, carotenoid 
production was continuously enhanced as ethanol was added and the effect of ethanol 
was greatest at 3 and 5 days. From this result, it is assumed that ethanol increases the 
carotenoid production once cells are in the stationary phase [43]. A decrease in pH is 
also observed in X. dendrorhous cultures when they are grown with added ethanol. This 
pH drop is possibly the result of acetate accumulation in the culture, but regardless the 
carotenoid levels increase [43].  
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2.4 Metabolic engineering of S. cerevisiae 
The baker’s yeast Saccharomyces cerevisiae is a model organism for genetic and 
metabolic engineering. It is a Generally Recognized As a Safe (GRAS) organism, has a 
short life cycle, and is easy to culture [9].The genome is highly malleable and is 
responsive to rearrangements and manipulations by recombinant DNA technology, 
which is even further expedited by the availability of the complete genome sequence of 
S. cerevisiae published in 1996 [44]. It is a fairly robust and genetically stable host that 
is capable of production of fine and bulk chemicals with proper engineering [2, 9]. 
Strains are also being engineered for increased tolerance to ethanol and other end 
products, which makes S. cerevisiae more conducible to large scale fermentation [45].  
 
Development of more sophisticated methods in the field of recombinant DNA 
technology has enabled researchers to manipulate a given pathway of interest. This 
manipulation is a more direct approach for cell improvement and involves introducing 
specific genome perturbations such as modifying promoter strength of a gene, gene 
deletions, or establishing new genes and/or new metabolic pathways into the cell [44]. 
Metabolic engineering is a directed approach, which distinguishes it from classical 
applied molecular biology. Metabolic engineering generally includes two aspects. The 
first aspect is the analytical side, which involves analysis of the cells to identify the most 
promising targets for genetic manipulation. The second aspect is the genetic engineering 
of the cell that encompasses the actual construction of the genetic modifications into the 
cell [44]. Different targets for metabolic engineering in S. cerevisiae are as follows: 
improvements of productivity and yield, elimination of by-products, improvements of 
cellular properties and process performance, extension of substrate range, and extension 
of product range including heterologous protein production [44].  
 
The molecular toolset for transforming S. cerevisiae is constantly expanding. Over the 
past several decades, technologies have rapidly evolved enabling yeast to produce a 
broad range of molecules by synthetically altering the genome [46].  A large majority of 
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these systems involve plasmid DNA and vectors with tunable parameters such as 
promotor/terminator, selection markers, and CEN/ARS origins of replication [47]. The 
transformation of yeast with these unique plasmids often comes at a metabolic cost to 
the cell, which may include a decreased growth rate or a decrease in production of the 
desired products [48]. The choice of selection marker, for example, has varying side 
effects to the cellular metabolic burden. Auxotrophic markers (out of the various 
selectable markers available) dramatically changed the specific growth rate of the strain 
and the most significant plasmid load was found to be in a diploid S. cerevisiae yeast 
strain [47]. The same study showed that plasmid copy number is not always determined 
by the origin of replication. They demonstrated that the use of the dominant antibiotic 
marker KanMX completely masks the effects of different origins of replication but 
surprisingly does not affect the specific growth rate of the strain [47]. Research has also 
shown that introduction of centromeric plasmids may result in higher heterologous 
protein expression, which may cause a negative gene dosing effect on the cell [47, 49]. 
Indeed, there seems to be a large disconnect between the use of plasmid-borne systems 
and integrated DNA cassettes that should be taken into consideration when utilizing 
metabolic engineering for product formation in yeast.  
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Figure 4. Various aspects of metabolic engineering [44]. 
 
 
Metabolic engineering is rarely a straightforward process. Cellular metabolism, for 
example, has a high level of complexity in S. cerevisiae and is a limiting factor for 
analytical methods of metabolic engineering.  The two aspects of metabolic engineering 
(as seen in Figure 4) are both crucial in order to fully understand the interactions 
between enzyme concentrations, metabolite levels, and gene expression [44]. The 
isoprenoid production pathway in Saccharomyces is affected by a multitude of direct and 
indirect factors including the overexpression of HMG-CoA, the effect of ethanol on 
HMG-CoA activity, and yeast growth substrates. The regulation of HMGR has been the 
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main focus for isoprenoid biosynthesis ever since it has been shown to be the rate-
limiting step in the pathway [21-23]. This natural bottleneck observed in the pathway 
has been a target for overexpression in S. cerevisiae to increase mevalonate pathway 
product yields [10]. This approach has been shown to moderately increase the flux 
towards the mevalonate pathway for isoprenoid production such as carotenoids and non-
isoprenoid compounds like bisabolene ( as seen in Figure 5), a precursor to biofuel 
bisabolane [10, 50].  
 
 
 
Figure 5. Mevalonate pathway in yeast and the carotenoid biosynthesis pathway in X. 
dendrorhous [15]. 
 
 
Both E. coli [3] and S. cerevisiae [43] have been studied to understand the impact of 
overexpressing the isoprenoid biosynthesis pathway. E. coli has physical limitations for 
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accumulation of carotenoids in the cell membrane that is most likely already reached 
without any modifications to the cell storage capabilities. Yeast, on the other hand, are 
capable of storing large amounts of ergosterol inside of the cell [51]. The ergosterol 
pathway has been diverted for carotenoid production in noncarotenogenic species such 
as S. cerevisiae and Candida utilis. The knowledge of a number of carotenoid 
biosynthetic pathways has also provided for a unique toolbox of carotenogenic (crt) 
genes that can be used for carotenoid production in S. cerevisiae via strain engineering 
of the terpenoid biosynthesis pathway [51]. The strains have been successfully 
engineered to produce carotenoids and optimized through overexpressing the bottleneck 
HMG1 and deleting ERG9. The ERG9 gene encodes for squalene synthase, and deleting 
it disrupts the ergosterol biosynthesis pathway, thus increasing the flux towards 
carotenoid production [51].  
 
Carotenoids are intracellular components and are not naturally secreted outside of the 
cell during fermentation [45]. The most effective ways to increase β-carotene production 
involves either increasing the biomass production or to increase the efficiency of the 
carotenoid production pathway. Carotenoid synthesis is governed by the activity of the 
isoprenoid pathway enzymes [45]. Balancing enzyme expression and relative expression 
levels are still crucial to the stability of the cell and its natural metabolic functions [2]. 
Altering the copy number of the gene is a standard approach for increasing metabolic 
flux; however, changing the promotor strength, ribosomal binding strength, and stability 
of the mRNA and resulting proteins are all variables to test in the optimization process 
[2].  
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3. MATERIALS AND METHODS 
 
3.1 Materials 
3.1.1 Medium 
All medium was autoclaved at 121ºC. Heat sensitive antibiotics were sterile filtered and 
added to cooled media (56 ºC). For all agar plates, final agar concentration is 2% 
(wt/vol). Escherichia coli medium included Luria-Bertani broth (18 g/L tryptone broth, 5 
g/L yeast extract, 2 g/L NaCl) and Super Optimum (SOC) broth (20 g/L tryptone, 5 g/L 
yeast extract, 0.5 g/L NaCl, 2.5 mL/L 1M KCl, 10 mL/L 1M MgCl2, 10 mL/L 1M 
MgSO4, 20 mL/L 1M dextrose). 100 µg/mL Ampicillin (100 mg/mL) was used for 
selection purposes. S. cerevisiae medium included YPD medium (10 g/L yeast extract, 
20 g/L peptone, 20 g/L dextrose), YNB medium (1.7 g/L yeast nitrogen base without 
amino acids and ammonium sulfate, 20 g/L dextrose, 5 g/L ammonium sulfate). 300 
µg/mL of Hygromycin B (100 mg/mL, H2O) and 100 µg/mL Nourseothricin (100 
mg/mL, H2O) were used for selection. Buffer and solutions included LiAc/TE (100 mM 
LiAc, 1X TE pH 7.5), SS DNA/PEG/TE/LiAc (0.26 µg/µL salmon sperm DNA, 0.4 g/L 
PEG 3350, 1X TE pH 7.5, 100 mM LiAc), TE (100 mM Tris-Cl, 10 mM EDTA). All 
chemicals used in this work may be seen in Table 1. 
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Table 1. Chemicals 
Manufacturer Location Chemicals 
ACROS USA D(+)-glucose, agar 
Amresco USA Peptone, Yeast Nitrogen Base 
BDH Aristar USA HCl, Ammonium Sulfate 
Electron Microscopy Science USA PEG 3350 
EMD Chemicals Inc. Germany Yeast Extract 
Enzo Life Sciences USA Hygromycin B 
Fisher Scientific USA EDTA 
Jena Biosciences Germany Nourseothricin 
JT Baker  USA Antifoam B Silicone Emulsion, 
NaCl 
MP Biosciences USA LiAc 
Promega USA Tris-Cl 
Teknova USA NaOH, Tryptone Broth 
Tokyo Chemical Industry Co., 
LTD 
Japan Dodecane 
Trevigen Inc. USA Salmon Sperm DNA 
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3.2 Methods 
3.2.1 Cultivation and storage of E. coli 
The E. coli strain BW25113 (Table 2) was used for all plasmid constructions and 
cultivated in Luria-Bertani medium at 37ºC at 225 rpm. For selection and cultivation of 
transformants, LB agar plates and LB medium were supplemented with 100 µg/mL 
ampicillin. For long term storage, frozen stocks were made of each transformant by 
suspending cells in a ~17% glycerol solution followed by storage in cryogenic tubes at   
-80 ºC. 
 
3.2.2 Transformation of E. coli by electroporation 
The E. coli strain BW25113 was grown overnight at 37ºC in a 3 ml culture of LB 
medium. After 12 hours, 500 µL of the culture was back diluted into 50 mL of fresh LB 
medium. The diluted cells were incubated at 37ºC until they reached an OD600 of 0.4. 
The cells were harvested by centrifugation at 5000 rpm, washed twice with 20 mL ice 
cold sterile milliQ water, once with 10 mL ice cold sterile 10 % glycerol solution. After 
the final wash step, cells were resuspended in ~500 µL of 10% glycerol and added into 
sterile microcentrifuge tubes in 50 µL aliquots. Any extra aliquots were stored in the       
-80 ºC freezer. For electroporation, 2 µL of cleaned DNA was added to 50 µL of 
competent cells and allowed to sit on ice for 5 minutes. The mixture was pipetted into a 
sterile cuvette and contents were electroporated at 25 µF, 200 ohms, and 1800 V. 1 mL 
of SOC recovery medium was added to the cuvette and cells were incubated at 37ºC for 
one hour.  
 
3.2.3 Cultivation and storage of S. cerevisiae 
All yeast strains were grown at 30ºC in solid or liquid YPD growth medium with 2% D-
glucose. For selection of hygromycin B resistant transformants, YNB agar plates 
supplemented with 300 µg/mL of hygromycin B were used. For selection of 
nourseothricin resistant transformants, YNB agar plates supplemented with 100 µg/mL 
of nourseothricin were used. Yeast were plated on YPD agar plates at room temperature 
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for short term storage. All yeast strains used in this work may be seen in Table 2. For 
long term storage, frozen stocks were made of each transformant by suspending cells in 
a ~17% glycerol solution followed by storage in cryogenic tubes at -80 ºC. 
 
 
Table 2. Organisms 
Organism Strain Genotype Reference 
E. coli BW25113 rrnB3 ΔlacZ4787 hsdR514 
Δ(araBAD)567 
Δ(rhaBAD)568 rph-1 
Barry Wanner 
S. cerevisiae FY2 
(GSY1136) 
Matα, ura3-52, gal+ in S288c 
background, 
YBR209W::Act1p-GFP-
Act1t-URA3 
Kao and 
Sherlock 
(2008) [52] 
 YLH1 GSY1136::YIplac211YB/I/E Reyes et al. 
(2014) [53] 
 YLH2 GSY1136::YIplac211YB/I/E 
ΔCTT1 
Reyes et al. 
(2014) [53] 
 SM14 YLH2 mutant P1A2. Isolated 
hyper-producer from 
evolution experiment. 
Reyes et al. 
(2014) [53] 
 YMO1 SM14::CTT1 This work 
 YMO3 YLH2::CTT1 This work 
 YMO2 SM14::CTT1, 
pAG36::TDH3p-tHMG1-
ACTp 
This work 
 YMO4 YLH2::CTT1, 
pAG36::TDH3p-tHMG1-
ACTp 
This work 
 25 
 
3.2.4 Transformation of S. cerevisiae by heat shock 
A modified lithium-acetate method was used for heat shock transformations [54, 55]. 
Cells were grown overnight at 30ºC in 3 mL of YPD medium. After 12 hours, roughly 
500 µL of overnight culture was added to 50 mL of YPD medium for an OD600 of 0.05. 
Diluted cells were incubated at 30ºC for 4-5 hours until the OD600 was 0.6. Cells were 
harvested by centrifugation, washed twice with 30 mL sterile water, once with 10 mL 
LiAc/TE, resuspended in 100 µL of LiAc/TE, and incubated at 30ºC for 30 minutes 
without agitation. To a sterile microcentrifuge tube, components were added in the 
following order: 20 µL DNA, 10 µL of 10 mg/mL single stranded salmon sperm DNA, 
300 µL of PEG/LiAc/TE, 50 µL of competent cells. Tubes were gently inverted to mix 
and incubated at 30ºC for 30 minutes without agitation. Cells were then heat-shocked for 
20 minutes at 42ºC, pelleted, and resuspended in 1 mL of YPD medium. After one hour, 
cells were washed and resuspended with 1 mL of sterile water. 100 µL of culture was 
plated on selective plates and plates were incubated at 30ºC for 2-3 days. 
 
3.2.5 Construction of CTT1 integration plasmid 
Plasmid pAG26 with hygromycin B selection (Table 3) was used as the backbone vector 
for construction of the CTT1 integration plasmid. The CTT1 sequence was amplified 
from genomic DNA of wild type FY2 S. cerevisiae using primers F-CTT1-HindIII and 
R-CTT1-SalI, digested with HindIII and SalI and ligated into pAG26 cut with the same 
enzymes. The downstream portion of CTT1 for marker recycling purposes was 
amplified using primers F-DSCTT1-ClaI and R-DSCTT1-SpeI (Table 4), digested with 
ClaI and SpeI and ligated into pAG26 cut with the same enzymes. Once constructed, the 
plasmid was electroporated into E. coli strain BW25113 and plated on LB agar plates 
supplemented with 100 µg/mL of ampicillin. The plasmid was digested with StuI and 
PvuII prior to transformation to ensure proper integration at the CTT1 gene site. 
Transformation colonies were selected and grown in 3 ml LB with 100 µg/mL 
ampicillin. A frozen stock was saved for long term storage and plasmid extractions were 
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verified using PCR. Once confirmed of having the right construct, plasmids were 
transformed into yeast strains using the lithium-acetate method [54, 55].  
 
3.2.6 Construction of truncated HMG1 overexpression plasmid 
The truncated HMG1 gene involved in the mevalonate pathway was PCR amplified 
from genomic DNA of wild type FY2 S. cerevisiae using AccuraTM High Fidelity DNA 
Polymerase. The overexpression plasmid was constructed by first digesting the 
yEpGAP-cherry plasmid (containing the TDH3 promotor) with EcoRI and XhoI, and gel 
extracting the plasmid without the yeast enhanced monomeric red fluorescent protein 
(yEmRFP). The tHMG1 PCR was digested with EcoRI and XhoI and ligated into the 
backbone vector of yEpGAP. The ligation product was transformed into BW25113 E. 
coli and selected on LB plates with 100 µg/ml ampicillin. Transformants were verified 
via colony PCR. Primers F-ACTt-XhoI and R-ACTt-SalI were used to amplify the ACT 
terminator sequence from plasmid pKKGS4 (Table 3 and 4). The PCR amplified ACT 
terminator and the yEpGAP::tHMG1 plasmid were digested with XhoI and SalI and 
ligated at room temperature for 2 hours. The ligated plasmid was transformed and 
propagated into BW25113 E. coli in LB with ampicillin. The TDH3p:tHMG1:ACTt 
construct was cut from the yEpGAP plasmid using restriction enzyme BamHI and 
ligated into pAG36 with nourseothricin resistance. The ligated plasmid was transformed 
and propagated into BW25113 E. coli under ampicillin selection, and further 
transformed into yeast using the lithium-acetate method [54]. 
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Table 3. Plasmids  
Name Marker Description Reference 
yEpGAP-cherry Amp, RFP Source for TDH3 
promoter 
Neta Dean 
pKKGS4 Amp Source for ACT 
terminator 
Katy Kao 
pAG26 (Addgene 
35127) 
Amp/hph/URA3 CEN plasmid with 
Hygromycin B 
selection 
John McCusker 
[56] 
pAG36 (Addgene 
35126) 
Amp/NAT/URA3 CEN plasmid with 
Nourseothricin 
selection 
John McCusker 
[56] 
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Table 4. Oligonucleotides  
Name Sequence Description 
F-CTT1-HindIII 5’-TGAGAAGCTTGAGC 
TGCTAAACATTAA-3’ 
Forward primer to amplify CTT1 
gene from FY2 
R-CTT1-SalI 5’-TGAGGTCGACTTAA 
TTGGCACTTGC-3’ 
Reverse primer to amplify CTT1 
gene from FY2 
F-DSCTT1-ClaI 5’-TGAGATCGATGGCA 
GCACTATTTATT-3’ 
Forward primer to amplify 
downstream of CTT1 gene from 
FY2 
R-DSCTT1-SpeI 5’- TGAGACTAGTGAGA 
TAGGTGGAATCTTA -3’ 
Reverse primer to amplify 
downstream of CTT1 gene from 
FY2 
F-tHMG1-EcoRI 5’-TGAGGAATTCATGG 
ACCAATTGGTGAAAA-3’ 
Forward primer to amplify 
tHMG1 from FY2 
R-tHMG1-XhoI 5’-TGAGCTCGAGTTAG 
GATTTAATGCAGG-3’ 
Reverse primer to amplify 
tHMG1 from FY2 
F-ACTt-XhoI 5’-TGAGCTCGAGCAAA 
TAGGCGGC-3’ 
Forward primer to amplify ACTt 
from pKKGS4 
R-ACTt-SalI 5’-TGAGGTCGACTTAC 
GCGCTTTTCC-3’ 
Reverse primer to amplify ACTt 
from pKKGS4 
 
 
 
 
 
 
 
 29 
 
3.2.7 Quantitative characterization of carotenoid levels 
Quantification of carotenoids was done as described previously with the following 
modifications [53]. 500 μL of cell culture was transferred to a 2 mL collection tube and 
cells were collected via centrifugation at 12,000 rpm for 2 minutes. Supernatant was 
aspirated and the pelleted cells were disrupted in 1 mL of dodecane and approximately 
250 μL of 425-600 μm acid-washed glass beads (Sigma). Disrupted culture was 
centrifuged for 2 minutes at 12,000 rpm and 200 μL of the supernatant was transferred to 
a Corning® 96 well black-wall clear-bottom plate for further quantification.  
 
3.2.8 Bioreactor studies 
Both YPD and YNB media supplemented with 2% (wt/vol) D-glucose were used for 
bioreactor studies. The seed cultures for fermentation were started using a 1 mL frozen 
culture stock (thawed) into 50 mL of media. Frozen culture starter stocks were created 
from an initial YPD batch-mode bioreactor run, which were then used to inoculate 50 
mL baffled flasks. Seed cultures were grown for 48 hours at 30°C and 170 rpm. The 50 
mL culture was used to inoculate 3 L of media in a 7 L bioreactor. Bioreactor studies 
were conducted in a 7 L glass bioreactor (Applikon®) for 72 hours. Bioreactor pH was 
maintained at set point using 2 M NaOH and 2 M HCl. The temperature was maintained 
at 30°C with an agitation speed of 800 rpm and continuous air flow.   
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4. RESULTS 
 
4.1 Impact of bioreactor parameters on carotenoid production 
β-carotene production and the metabolic profiles of each batch run varied based on 
media composition, agitation speed, and pH. Bioreactor runs were conducted with either 
YPD or YNB media and at an agitation speed of 400 or 800 rpm. The pH levels tested 
were 4, 4.5, and 5. YPD is a complete media, which results in a high titer (mg β-
carotene/L) and biomass (g/L); however, it also results in performance variability due to 
the yeast extract in the culture medium. Conversely, YNB is a defined media that allows 
for reproducibility and higher β-carotene production (mg β-carotene/g [dcw]) at the 
exchange of a lower final biomass. Another variable is agitation speed, which affects the 
amounts of aeration and dissolved oxygen (DO) levels in the bioreactor. 
Carotenogenesis is an aerobic process [57], so the agitation speed influences both 
carotenoid production and metabolite concentrations. The maximum observed drop in 
DO for each run happens during the exponential growth phase when cells are consuming 
the most oxygen. The maximum DO drop for runs at 400 rpm is 80-90% and only 40-
50% for runs at 800 rpm. At 800 rpm, the β-carotene production follows a linear trend 
throughout the run. When the agitation speed is lower, there is an evident lag time in β-
carotene production, as shown in Figure 6. This lag time is most likely the result of 
limiting oxygen in the bioreactor.  Despite the different production profiles, the final 
amounts of β-carotene produced are similar between the two agitation speeds. Aeration 
level also affects the ethanol consumption rate in the bioreactor. For most runs at 800 
rpm, ethanol is consumed within 24 hours; however, ethanol takes about twice as long to 
be consumed when agitation is at 400 rpm.  
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Figure 6. Effect of aeration on SM14 carotenoid titer in correlation with pH. YNB 
medium, varying agitation speed and pH.  
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Figure 7. Effect of aeration on SM14 carotenoid production with respect to growth 
medium and pH. 
 
pH is the variable that has the most affect on β-carotene production and metabolite 
concentrations. In YPD media, pH has very little if any affect on carotenoid production. 
The deviations of carotenoid production in YPD media are based on substrate 
irregularities, specifically in yeast extract. YNB media, however, responds to pH 
fluctuations and the results are consistent between each replicate of specific run 
conditions. The natural pH of the carotenoid S. cerevisiae yeast cultures in the bioreactor 
is around pH 3.0. β-carotene production in YNB media is highest at pH 4.0 and 
production decreases as pH increases, as shown in Figures 7 and 8. In YNB media at pH 
4.5 and 5.0, glucose exhaustion happens around 12 hours and ethanol consumption ends 
around 24-30 hours. In YNB media at pH 4.0, metabolite analysis reveals a trend of 
slower glucose and ethanol consumption in comparison to the higher pH counterparts. 
Both glucose and ethanol took twice as long to be consumed: glucose in around 24 hours 
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and ethanol in around 60 hours. This trend was seen in other isolated mutants from the 
two different populations (SM12 and SM22) as well as the ancestral strain (YLH2) runs. 
SM12 is from the same population as SM14 and SM22 is from a separate evolved 
population [53], demonstrating that the metabolic profile result is consistent across 
different genetic backgrounds.  
 
 
 
Figure 8. Maximum β-carotene produced in batch bioreactor. Agitation at 800 rpm, YNB 
medium, 72 h run time. 
 
 
 
Acetic acid, which was another measured metabolite, also had varying concentrations 
throughout the run time and differed between runs of different parameters. At 400 rpm 
there is an observed spike in acetic acid concentration by hour 60, which is reproducible 
across all runs at 400 rpm and different media types. By 60 hours the ethanol is depleted, 
acetate concentration rises, and the β-carotene productivity rate increases as seen in 
Figure 9. Acetate concentrations in YPD batch runs with an agitation of 800 rpm stay 
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around 2-4 mM and there is not a very clear trend for correlating acetate to carotenoid 
production levels.  In YNB media with 800 rpm agitation and pH range of 4 to 5, the 
acetate concentration increases with carotenoid production levels. After 12-18 hours post 
ethanol depletion, the acetate is consumed and the bioreactor biomass reaches a 
maximum, as seen in Figure 9. This phenomenon is observed in SM14, the ancestral 
strain YLH2, and the two other isolated single mutants tested (SM12 and SM22).  
 
 
 
Figure 9. Carotenoid titer, biomass, and metabolite comparison of YNB batch run of 
SM14 and YLH2 (ancestral strain). 800 rpm, pH 4. ----: denotes ancestral strain values. 
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4.2 Metabolic engineering of S. cerevisiae 
In previous work, the CTT1 catalase gene was removed from the genome in order to 
have more effective hydrogen peroxide shock experiments. The removal of the CTT1 
gene reduced carotenoid expression in the unevolved ancestral strain by ~43% decrease 
[53]. To test whether carotenoid levels would increase with the CTT1 gene back in the 
genome, we reintegrated CTT1 into the isolated single mutant SM14 and the ancestral 
strain YLH2. What we saw was that reintroduction of CTT1 increased β-carotene titer 
only in the SM14 strain. The increase was from 15.1 ± 3.25 mg/g [dcw] to 22 ± 2.1 mg/g 
[dcw], as seen in Figure 10.  
 
The second aim to further increase carotenoid production in our strains utilized 
metabolic engineering to introduce tHMG1, which is the known rate-limiting step in the 
mevalonate pathway. To our surprise, overexpression of tHMG1 did not substantially 
increase β-carotene production in the strains. The presence of the empty plasmid in the 
strains also reduced carotenoid production, as seen in Figure 10. This may demonstrate 
that the self-replicating plasmid poses a metabolic burden on the cell and negatively 
influences carotenoid production.  
 
 36 
 
 
 
Figure 10. β-carotene quantification comparison between strains with tHMG1 and 
CTT1. All strains were in 3 ml YPD cultures grown at 30°C for 72 hours. EP: empty 
plasmid control. tHMG1 p1, p2, p4: “p” represents plasmid and 1, 2, 4 are three different 
isolated transformants with the tHMG1 overexpression plasmid construction. Each strain 
contains at least three biological replicates. ** = p < 0.01; (two-tailed Student’s t-test 
with unequal variance). 
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5. DISCUSSION 
 
Yeast cells are exposed to a multitude of stress and metabolic challenges through 
industrial fermentation. There are physical stresses such as pressure and cell shearing, 
and chemical stresses in the form of osmotic shock, oxidative stress, and feedstock, 
metabolite, and product toxicities [28].  Increased stress has been shown to effect the 
metabolic activity and longevity of yeast, which ultimately hinders fermentation 
performance [28]. Both redox homeostasis and cell rescue/defense/virulence were found 
to be functionally enriched in the initial stages of fermentation. Both of these functions 
use genes involved in oxidative stress protection [28]. The ergosterol biosynthesis 
pathway, which has the same precursors as the carotenoid biosynthesis pathway, is 
highly connected to oxidative stress of the cell. A deficiency in ergosterol production 
elevates oxidative stress in yeast, demonstrating the importance of a well-functioning 
mevalonate pathway for cellular homeostasis [28, 58, 59]. 
 
The main objective of this work was to increase β-carotene production in our isolated 
hyper-producer carotenoid S. cerevisiae strains. The first goal was to optimize the 
growth conditions in the bioreactor to determine which parameters most affect β-
carotene production. Despite the similar metabolic profiles of the evolved mutants and 
the ancestral strain, there is a very drastic difference in the β-carotene titer productivity 
rates between the two strains. In the evolved mutants, from the initial start of 
fermentation and consistently throughout the run, there is a large positive upward slope 
of β-carotene production. The β-carotene production in the ancestral strain appears to 
stay at a near constant level within a 72-hour fermentation, as seen in Figure 9. Studies 
have shown an enriched cellular defense response in the initial hours of fermentation 
[28], which in combination with our evolved strains may encourage the higher 
productivity rates.  
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We found that metabolite concentrations in the bioreactor are somewhat dependent on 
media composition, agitation, and pH. The different parameters and resulting metabolic 
profiles also reflect the extent of β-carotene production in the cell. In our experiments, a 
dramatic increase in the production of β-carotene occurs after the glucose substrate has 
been consumed. A similar trend was seen in a study using S. cerevisiae for bisabolene 
production, which used the same pathway and precursor enzymes as those for β-carotene 
production [15]. During the time of glucose exhaustion and the beginning of ethanol 
consumption at around 12 hours, the carotenoid titer undergoes a dramatic shift towards 
higher productivity rates. Research has correlated ethanol and acetate concentration to 
increased activity in the isoprenoid pathway in yeast [19]. Ethanol enhances the activity 
of HMG-CoA reductase and increases the amount of mevalonate in the cell. Acetate is 
the precursor to acetyl-CoA, which is the center of cellular metabolism and is also the 
first compound of the MVA pathway. If both ethanol and acetate increase the activity of 
the MVA pathway, there will be an increase in the activity of the pathway enzymes and 
accumulation of the pathway precursor compounds. This heightened activity translates to 
increased formation of the downstream products of the MVA pathway such as β-
carotene.  
 
The second approach to increase β-carotene production was through metabolic 
engineering of our yeast strains. Reintroduction of the cytosolic catalase T (CTT1) gene 
and overexpressing the truncated HMG1gene provided varied results for β-carotene 
production in our strains. It has been previously demonstrated in E. coli that the 
isoprenoid pathway is a complex phenotype and that combinations of gene deletions or 
expressions have the potential to increase lycopene production [17]. This complexity 
may also be seen in our carotenoid strains for the production of β-carotene. When CTT1 
was reintroduced into YLH2 and SM14, only SM14 responded with an increase in β-
carotene. It may be possible that catalase reduces oxidative stress in the cell, which then 
prevents oxidation of the carotenoids [37]. However, the reintroduction of CTT1 into the 
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ancestral strain did not increase carotenoids production; the reason for the different 
observations between the two strains is currently not known.  
 
To further increase the fatty acid content and carotenoid content of the cell, tHMG1 was 
overexpressed on a self-replicating CEN plasmid. The transformation of the plasmid was 
only stable with the yeast strains containing CTT1 (YLH1). For strains lacking CTT1 
(such as the hyper-producers and the ancestral strain), the transformation did not work 
and either the cells did not grow or they were petites. Once the CTT1 gene was 
reintroduced into the strains, only then was the transformation successful. The reason for 
this result is still unknown. The carotenoid hyper-producer SM14 with CTT1 does not 
respond to overexpression of tHMG1, which has been previously shown to increase β-
carotene production in S. cerevisiae by over 400% when the gene was integrated into the 
yeast genome [10]. An explanation for our negative result may be a gene dosage effect 
or that the CEN plasmid creates excess metabolic burden on the cell [49]. 
 
Our mutant strain SM14 produces the highest amount of β-carotene in S. cerevisiae 
reported to date [10], 18 ± 1 mg/g [dcw] β-carotene compared to the current highest 
reported value of 5.9 mg/g [dcw].  There are other routes currently under investigation to 
further improve β-carotene production in yeast. One route is the fatty acid β-oxidation 
pathway. This pathway is not directly involved in the mevalonate pathway and includes 
genes involved in fatty acid synthesis as well as genes involved in the degradation of 
fatty acids. Indeed, more thorough investigation is needed in order to optimize our 
strains for carotenoid production.  
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6. CONCLUSIONS 
 
Carotenoid production in S. cerevisiae is of a complex phenotype. The goal of our 
experiments was to increase the β-carotene production of our current hyper-producer 
strains. We targeted two aspects: optimizing growth conditions in the bioreactor and 
metabolically engineering the mevalonate pathway in our strains. We determined the 
effect of various bioreactor parameters on β-carotene production in our hyper-producer 
SM14 mutant strain that included aeration, pH, and media composition. Dissolved 
oxygen content inside the bioreactor influenced the profile of carotenoid production, but 
final titer of carotenoids was independent of the aeration. The pH level only influenced 
batch runs using defined media (YNB), where runs at pH 4 resulted in β-carotene 
production of 16.2 ± 1.4 mg/g [dcw] and pH 5 resulted in lower β-carotene production at 
10 ± 0.1 mg/g [dcw]. The cytosolic catalase T (CTT1) gene was reintegrated back into 
the yeast genome; however, improvement in β-carotene production was only observed in 
SM14 and not the ancestral strain. Overexpression of the bottleneck HMG1 in the MVA 
pathway did not increase carotenoid production in the strains, suggesting that there may 
be a gene dosage effect or the introduced CEN plasmid creates too high of a metabolic 
burden on the cell. This work demonstrates that bioreactor culture parameters as well as 
genome manipulations influence the production of carotenoids in S. cerevisiae. 
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1. Evolved Osmotolerant Escherichia coli Mutants Frequently Exhibit Defective N-
Acetylglucosamine Catabolism and Point Mutations in Cell Shape-Regulating 
Protein MreB. Winkler, J., C. Garcia, M. Olson, E. Callaway, and K. C. Kao. Appl. 
Environ. Microbiol. 2014, 80(12): 3729-3740. 
 
Escherichia coli, an important industrial microorganism for the production of a wide 
variety of fine chemicals, fuels, and proteins, has been extensively targeted to improve 
its suitability as a biofactory. Strain development efforts have focused on improving 
tolerance of feedstocks containing toxic compounds [60, 61] or products [62, 63]. Many 
environmental variables, including osmotic pressure, can negatively impact biocatalyst 
performance [64]. Use of nonconventional waste streams, such as waste glycerol or 
brackish water sources, to support microbial growth can also reduce process costs [65, 
66] while reducing pressure on fresh water resources; however, these carbon and water 
sources generally contain high concentrations of salt that may be inhibitory to microbial 
growth. In addition to osmotic stresses, excess Na+ can disrupt the ion homeostasis in E. 
coli as well [67]. Previous studies have attempted to engineer improved osmotic 
tolerance in E. coli [68, 69], but overall, knowledge of the genetic mechanisms that 
confer tolerance of osmotic stress in general or to specific osmolytes remains limited. A 
detailed analysis of E. coli osmotolerance to osmolytes would therefore provide new 
insight into the molecular mechanisms underlying this complex phenotype. 
 
Adaptive laboratory evolution [70] is a promising approach to identify potentially novel 
osmotic tolerance mechanisms, as this technique requires no assumptions about the 
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underlying genotype-phenotype relationship. Complex phenotypes, such as enhanced 
resistance to biofuels [62, 63, 71], lignocellulosic hydrolysates [61, 72], antibiotics [73, 
74], and environmental conditions [75], have all been successfully characterized using 
this approach. In this study, sodium chloride (NaCl) was selected as the osmotic 
inhibitor. A recent evolutionary study aimed at characterizing cross-adaptation between 
several different stressors detected several potential mechanisms in a single evolved 
NaCl-tolerant isolate [76], but due to the possible existence of multiple adaptation 
mechanisms, additional information is needed to better understand the genetic bases of 
osmotolerance. 
 
In order to identify novel genetic mechanisms for osmotic (NaCl) tolerance, we have 
utilized adaptive laboratory evolution to generate osmotic-tolerant mutants of two 
distinct E. coli strains: one capable of in situ recombination to reduce clonal interference 
between osmotolerant mutants and another, completely asexual strain [74]. These strains 
will enable a comparison between the sexual evolution system and typical evolutionary 
engineering approaches for an industrially relevant phenotype. After being propagated 
for approximately 150 generations in the presence of increasing concentrations of NaCl, 
osmotolerant mutants were isolated, characterized, and sequenced to identify any genetic 
changes that occurred during evolution. The elucidated resistance mechanisms were then 
explored phenotypically to better understand their potential impact on E.coli physiology. 
Transcriptomic analyses of several mutants were subsequently conducted to better 
characterize the genotype-phenotype connection that resulted in enhanced 
osmotolerance. 
 
 
MATERIALS AND METHODS 
 
Bacterial strains and growth media. All strains used for evolution in this study were 
previously developed BW25113 derivatives [74]. Briefly, Hfr-2xSFX− is a conjugation-
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proficient, surface exclusion-deficient Hfr strain with an operon of F transfer proteins 
integrated at the trp locus [77]. Recombination is therefore more frequent for the Hfr-
2xSFX− strain than for an Hfr strain with intact surface exclusion, which acts to prevent 
redundant transfer between Hfr and F+ strains [78]. 2xOriT, an F− strain, was used as an 
asexual control. Knockout strains were obtained from the Keio collection [79], while 
ASKA overexpression plasmids were transformed into BW25113 from the original AG1 
host [80] for both overexpression and compensatory assays. The kanamycin resistance 
marker in the Keio strains was also removed by transformation with pCP20 as needed 
for strain construction and screening [81]. The full list of strains and plasmids used in 
this study is given in Table S1 in the supplemental material. Minimal M9 medium 
supplemented with 0.5% (wt/vol) glucose and 50 μg/ml tryptophan [74, 77] was used for 
routine cultivation and growth assays, while Luria-Bertani (LB) broth and agar plates 
were used for strain isolation, transformation, and other analyses where indicated. 
Sodium chloride (JT Baker) was utilized to adjust the osmotic strength of the medium 
during the evolution and for subsequent growth assays. 
 
Evolution experiment. Adaptive laboratory evolution was conducted via serial batch 
transfer experiments to improve the osmotic stress tolerance of Hfr-2xSFX− and 2xOriT 
in parallel. Six replicate populations for each strain were inoculated from independent 
colonies to initiate the evolution experiment in 0.55 M (32 g/liter) NaCl and increased to 
0.6 M (35 g/liter) NaCl after one serial transfer. Approximately every 24 h, a proportion 
(typically 1 to 3%, based on cell density) of each replicate population was diluted into 
fresh medium to ensure that each population underwent approximately 6 or 7 
generations per transfer for a total of 150 generations. Sodium chloride concentrations 
were periodically increased from 0.6 M to 0.75 M (32 to 35 to 44 g/liter), as fitness 
increases were observed in population level data every 24 generations (Fig. 1); the daily 
concentration of NaCl in each replicate set is shown in Fig. S1 in the supplemental 
material. The initial NaCl concentration was chosen to reduce the growth rates of the 
ancestral strains by approximately 50%. The fitness (S; equation 1) of the evolving 
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populations relative to their ancestral parents was determined every 24 generations using 
growth assays in microtiter plates to track their rates of adaptation; 0.6 M (35 g/liter) 
NaCl was used for the initial fitness measurement at generation zero to account for the 
lower initial tolerance of the Hfr strains, and 0.65 M (38 g/liter) NaCl was used 
thereafter. The specific growth rate (μ) was calculated by linearizing the measured 
growth curves and calculating the slope in exponential growth phase using standard 
regression procedures. The subscript i refers to the measured growth rate for the ith 
population or mutant under investigation. 
 
A logarithmic model (equation 2) was then fitted to the fitness measurements (S; see 
below) for each population and used to calculate their overall rate of improvement 
throughout the evolution experiment based on the expected shape of the improvement 
curve [75], where the constant α is a shape parameter for the logarithmic curve. The 
variable t refers to the number of generations that have occurred since the initial 
inoculation of the experiment. Potential external contamination and cross-contamination 
of the experiment were monitored as described by Winkler and Kao [74]. 
𝑆 =  
𝜇𝑖
𝜇2𝑥𝑜𝑟𝑖𝑇
− 1            (1) 
𝑆(𝑡) =  𝛼 log (𝑡)             (2) 
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Figure 1. Average fitness improvements for the Hfr-2xSFX− and 2xOriT populations, 
relative to the 2xOriT parent strain during evolution in the presence of high sodium 
chloride concentrations. NaCl concentrations used during fitness assays were 0.6 M (35 
g/liter) for the first measurement and 0.65 M (38 g/liter) for all subsequent 
measurements. Fitness is defined as S = μpop/μ2xOriT − 1 in this case, where pop refers 
to the population average growth rate for each evolving population under NaCl 
challenge. Error bars are 95% confidence intervals using the Student t distribution [82]. 
Mutant isolation and screening. One clonal isolate was randomly obtained from each 
evolved population (to ensure mutational independence) at the end of the evolution 
experiment after streaking the evolved populations onto LB agar for single colonies. 
Isolates from the Hfr- 2xSFX−  and 2xOriT populations are prefaced with G and A, 
respectively. All isolates were propagated in M9 minimal medium without excess NaCl 
for at least 10 generations prior to any phenotypic analysis. All cultures were grown in 
glucose minimal medium with tryptophan overnight and diluted 100-fold (optical 
density at 600 nm [OD600] ≈ 0.04) into medium containing various stressors for growth 
over 24 to 36 h. Cross-adaptation was analyzed using several general stress conditions 
(excess glucose [54 g/liter], n-butanol [0.8% vol/vol], mild acid stress pH [pH = 6.0], or 
elevated temperature [42°C]) with two biological and 4 technical replicates per strain per 
condition. While these stressors would be more severe in an industrial fermenter, the 
purpose of this assay is to analyze incidental phenotypic changes associated with 
osmotic tolerance. All growth assays were performed in 96-well microtiter plates using a 
plate shaker and incubator (TECAN Infinite M200) at 37°C (except for thermal stress 
assays). Relative fitness (S) and improvement (RI) of the ith mutant were, respectively, 
calculated for each condition using equations 1 and 3. Subscripts C and U refer to 
challenged and unchallenged maximum growth rates, respectively, where C can be any 
of the stress conditions listed above and sodium chloride stress. 
Fitness assays for knockout, overexpression, and compensatory assays were conducted 
in screw-cap tubes with 5 ml of M9 minimal medium, supplemented with glucose, 
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tryptophan, and 0.55 M (32 g/liter) NaCl. A lower concentration of NaCl was used for 
these assays to permit gathering of a full growth curve within 24 h. OD600 readings 
were taken every 2 h until exponential growth had been sustained for at least 3 
doublings. Fitness of the overexpression and knockout strains relative to the appropriate 
references (empty vector controls for the overexpression strains, BW25113 for knockout 
strains) was then calculated using equation 1. Three biological replicates per strain were 
analyzed. 
𝑅𝐼 =  
𝜇𝑖,𝐶 𝜇𝑖,𝑈⁄
𝜇2𝑥𝑂𝑟𝑖𝑇,𝐶 𝜇⁄ 2𝑥𝑂𝑟𝑖𝑇,𝑈
− 1    (3) 
 
Fitness distribution analysis. Six randomly isolated clones were obtained by streaking 
from each of the evolved Hfr-2xSFX− and 2xOriT replicate populations (for a total of 36 
random isolates per strain). Each colony was inoculated into 2 ml glucose minimal 
medium supplemented with tryptophan and allowed to grow for 24 h. The fitness of each 
isolate (relative to 2xOriT) was then determined using growth in a microtiter plate under 
0.65 M (38 g/liter) NaCl challenge, as described previously. Four technical replicates 
were used per screened isolate. 
Mutation rate under osmotic stress. The mutation rates of Hfr- 2xSFX− and 2xOriT 
were measured using a standard fluctuation test [83] under 0.55 M (32 g/liter) NaCl 
stress to determine if the strains have unequal mutation rates under osmotic stress, which 
would influence their relative adaptation rates. For 2xOriT, the mutation rate is 1.43 
mutants per 109 cells (95% confidence interval of 0.72 to 2.31); for Hfr-2xSFX−, the 
mutation rate is 1.52 mutants per 109 cells (95% confidence interval of 0.71 to 2.54). 
The difference in mutation rate between the strains is not statistically significant. 
Hyperosmotic shock tests. Single colonies of each isolate (G1 to G6 and A1 to A6) and 
the parental controls were inoculated into glucose minimal medium and allowed to grow 
overnight. The stationary-phase cultures were then diluted in fresh medium and 
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propagated until mid- exponential phase (OD600 ≈ 0.3 to 0.6). The cultures were then 
normalized to equivalent optical densities, pelleted, and resuspended in glucose minimal 
medium supplemented with 5.45 M (319 g/liter) NaCl and incubated at 37°C for 2 h. 
Each sample was then serially diluted up to 10,000-fold in minimal medium, spotted on 
LB plates, and incubated overnight at 37°C. The numbers of colonies in each 1,000X to 
10,000X dilution were then counted. Each assay was performed in duplicate with 
independent biological replicates. 
Genome sequencing and verification. The evolved Hfr-2xSFX− (G1 to G6) and 
2xOriT (A1 to A6) isolates, along with the unevolved parental strains, were sequenced to 
discover the genotype underlying the observed sodium chloride tolerance. Genomic 
library preparation and sequencing were performed by The Texas A&M Genomics 
Center for sequencing on the Illumina HiSeq 2500 platform using 100-bp single-end 
reads. An average of 286-fold coverage was obtained for each isolate. Reads were 
assembled against the MG1655 reference genome, and each mutant genome was 
compared to the parental sequences to identify any de novo mutations. The approach to 
mutation verification depended on the type of mutation; 11 single nucleotide 
polymorphisms (SNPs) and deletions were verified with Sanger sequencing, and other 
large deletions were verified with junction-specific PCR (see Table S2 in the 
supplemental material). 
Transcriptional analysis. Two biological replicates of A2, A4, G2, G3, G5, and G6 
were used for microarray analysis. Two colonies of each strain along with the 2xOriT (A 
parent) and Hfr-2xSFX− (G parent) were inoculated into glucose minimal medium 
supplemented with tryptophan and grown overnight at 37°C with shaking. A total of 500 
μl of each overnight culture was diluted 50-fold (OD600 ≈ 0.02) into 250-ml baffled 
flasks containing 25 ml of glucose minimal medium, supplemented with tryptophan and 
0.55 M (32 g/liter) NaCl. Samples were grown until reaching an OD600 of 
approximately 0.5 and were then harvested by rapid filtration (Nalgene) followed by 
immediate resuspension in 5 ml of RNAlater (Sigma). RNA processing was done as 
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described previously [84]. 
Indole and biofilm measurements. The G2, G3, G5, G6, A2, and A4 mutants, along 
with the Hfr-2xSFX− and 2xOriT parental strains, were grown in M9 medium 
supplemented with 0.55 M (32 g/liter) NaCl, 0.5% (wt/vol) glucose, and 50 μg/ml 
tryptophan until reaching stationary phase. Extracellular indole concentrations were 
measured using standard procedures with Kovac’s reagent [85]. Biofilm formation was 
measured in 96-well plates with 2 biological and 8 technical replicates per strain in 
either LB or glucose minimal medium supplemented with NaCl (0.55 M, 32 g/liter) and 
tryptophan using a previously established protocol [86]. Biofilm data are normalized by 
final biomass density (OD600) and by specific biomass formation of the parental strains. 
Microarray data accession number. Microarray data were deposited in the Gene 
Expression Omnibus (GEO) database under accession number GSE51611. 
 
RESULTS AND DISCUSSION 
Evolution under NaCl challenge. Six replicate populations of 2xOriT and Hfr-2xSFX− 
were subjected to gradually increasing NaCl concentration (0.55 to 0.75 M, 32 to 44 
g/liter) over the course of approximately 150 generations. Over this time course, 
significant fitness improvements were observed in all evolving populations (Fig. 1), 
indicating the successful selection for osmotolerant mutants in each population. 
Compared to the observed rates of fitness improvement in the 2xOriT populations (4.54 
X 10-3/generation), the rates of fitness improvement in Hfr- 2xSFX− populations are 
significantly larger (6.70 X 10-3/generation, P < 0.003, Student’s t test). However, it is 
possible that due to the initial higher sensitivity of Hfr-2xSFX− to NaCl, mutants with 
larger fitness improvements tended to arise in the sexual populations as a result of 
stronger selection, leading to an apparent increase in the adaptation rate independent of 
recombination. Interestingly, mutant isolates from the Hfr-2xSFX− populations tended 
to have higher relative fitness values than those from the 2xOriT populations, as 
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discussed below. All populations reached similar phenotypic endpoints by the 
conclusion of the experiment. No loss of mating competence was observed in the Hfr- 
2xSFX− populations over the course of the experiment. 
 
Figure 2. Relative fitness of Hfr-2xSFX− and 2xOriT isolates under several abiotic 
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stressors, including 0.65 M (38 g/liter) NaCl (A), 0.3 M glucose (B), 0.8% n-butanol (C), 
growth at 42°C (D), pH 6 (E), and without abiotic stressors (F). Error bars are 95% 
confidence intervals using the Student t distribution [82]. 
Mutant characterization. A single randomly isolated clone from each Hfr-2xSFX− (G1 
to G6) and 2xOriT (A1 to A6) population was subjected to detailed analyses to identify 
any novel phenotypes that arose during evolution alongside osmotolerance. All mutants 
had significant improvements in relative fitness under NaCl challenge (Fig. 2A), though 
is it possible that mutations that enhance growth in minimal medium [87] are responsible 
for the apparent tolerance increase. However, only G3 and G4 had significantly 
improved growth rates in the absence of stress (Fig. 2F). When the observed general 
fitness benefits in the absence of abiotic stressors were accounted for by calculating 
mutant relative improvements under NaCl stress (see equation 3), all mutants remained 
significantly more tolerant than the unevolved 2xOriT strain; these strains likely have 
acquired mutations beneficial to both growth in minimum medium and in NaCl-
challenged conditions. Furthermore, all isolated mutants were capable of growth at 0.80 
M (47 g/liter) NaCl, a concentration that completely inhibits growth of the 2xOriT and 
Hfr-2xSFX− parent strains. In light of the improved NaCl tolerance of the mutants, we 
also examined their ability to withstand prolonged shocks under hyperosmotic 
conditions (5.45 M, 319 g/liter NaCl). While most mutants had no improvements in 
survival relative to 2xOriT under these conditions (data not shown), G3 and G6 rapidly 
lost viability, exhibiting a 10-fold or more decrease in shock tolerance. It is possible that 
survival under extreme NaCl concentrations versus growth at lower concentrations 
requires divergent tolerance mechanisms. 
Osmotic tolerance and other complex phenotypes. Resistance to osmotic stress is 
known to affect other phenotypes of industrial interest, such as n-butanol or low pH 
tolerance [76, 88] and growth at elevated temperatures [89]. Growth assays of the 
mutants in the presence of inhibitory levels of glucose, 0.8% n-butanol, mild acidic pH, 
and thermal stress (Fig. 2B to E) revealed that the observed tolerance phenotypes are 
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mostly specific to NaCl resistance alone. The G3 and G4 isolates exhibited increased 
tolerance of stress-inducing glucose concentrations [69]. Glucose and thermal tolerance 
levels of the other isolates were generally similar to or slightly below that of the wild-
type reference, so it is unlikely that there is a fundamental incompatibility between 
osmotic tolerance and these phenotypes in general. The acid tolerance of the mutants 
varied widely for the Hfr mutants, with G5 and G6 exhibiting large (25 to 37%) declines 
in fitness even under mildly acidic pH. Significant but small decreases in relative fitness 
under acid stress were also observed in all A mutants. These results imply that there is 
some degree of antagonistic pleiotropy between tolerance of high osmotic pressures and 
acid stress, but additional investigation is needed to confirm this hypothesis. 
Interestingly, no isolate had improved n-butanol tolerance in this case, contrary to 
previous examples of n-butanol-osmotic stress cross-adaptation[62, 76]. The reasons for 
this apparent incompatibility are unclear, especially given that Dragosits et al. observed 
a slightly increased level of n-butanol tolerance in an isolate evolved under continuous 
0.3 M NaCl stress [76]. Stronger NaCl selection could disfavor mutations that also 
improve n-butanol resistance, as it is reasonable to expect that different levels of osmotic 
stress select for distinct tolerance mechanisms. n-Butanol tolerance is also not always 
associated with improved osmotic stress resistance in evolved mutants [88], so there are 
at least some evolutionary paths on both the NaCl and n-butanol landscapes that lead to 
divergent tolerance phenotypes. The overall lack of significant cross-adaptation for the 
isolates in this case does indicate that specialist mutants with adaptations specific only to 
NaCl tolerance are favored under these evolutionary conditions. 
Genetic patterns of adaptation. In order to better understand the genetic bases for the 
observed osmotolerance phenotypes and to compare tolerance mechanisms between the 
sexual and asexual populations, we sequenced the genomes of A1 to A6 (2xOriT parent) 
and G1 to G6 (Hfr-2xSFX− parent) isolates. A complete list of mutated genes, their 
putative functions, and the structure of each mutation in the isolates is given in Table 1. 
Many isolates (8/12) harbor likely inactivating frameshift mutations or large deletions 
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within the N-acetylglucosamine (NAG) catabolic operon (nag), either in the gene 
encoding the transcriptional repressor nagC or the deacetylase nagA. Amino sugar 
catabolism may therefore have been altered in these strains. Although this adaptation has 
not been previously observed in strains evolved under continual osmotic stress, NAG 
forms a crucial component of peptidoglycan [90], and it is readily conceivable that 
adaptation to high osmotic stress would involve alterations to cell wall biosynthesis or 
peptidoglycan recycling. Mutations affecting glucosamine-6-phosphate biosynthesis 
have also been identified in evolved isobutanol-tolerant E. coli [71], so this may be a 
common mechanism of adaptation to certain membrane-disrupting environmental 
conditions. Mutants A1, A2, and A3, all containing mutations in nagA, were unable to 
metabolize NAG as a sole carbon source as expected [91]. G4 unexpectedly failed to 
grow as well, despite the fact that the strain harbors no mutations affecting NAG genes; 
it is possible that this strain has a large genomic rearrangement affecting nagA 
expression that was not detected in our analysis. 
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Table 1. Mutations identified with genome sequencing [82]. 
 
Besides alterations in NAG metabolism, genes encoding cell shape regulators are 
frequently mutated in the evolved strains. Nonsynonymous SNPs in the cell shape-
regulating actin homolog mreB [92] and the peptidoglycan transpeptidase mrdA genes 
[93] were identified in five different mutants, suggesting that changes in cell 
morphology might also reduce osmotic stress on the cell. Microscope examination of the 
affected strains showed neither a gross difference in cell shape compared to parental 
controls (data not shown) nor abnormal filamentation, so the precise effect of these 
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mutations remains unclear. Coincidentally, a previous study examining mreB and mrdA 
mutations that suppressed an abnormal shape phenotype caused by RodZ deficiency [94] 
detected an identical SNP in mrdA, implying that RodZ activity may also be deficient 
under osmotic stress. It is difficult to speculate on how nag and mreB mutations might 
interact in the A1, A2, A5, and A6 mutants, as they affect related but distinct cellular 
processes; changes in mreB-chromosomal interactions may result in altered cell division 
or chromosomal segregation, which may in turn affect the amount of NAG precursor 
generated from peptidoglycan recycling. Given the seeming ubiquity of mutations 
affecting both pathways, it is clear that perturbation of cell shape proteins or 
peptidoglycan metabolism is important for osmotic tolerance. 
While both groups of mutants had similar mutation rates (see Materials and Methods), 
transposon insertions in fimA (type I fimbriae) and proV (the ATP binding cassette for 
the proVXW glycine betaine transporter) were observed only in the A strains. Fimbrial 
components, including fimA, are highly upregulated under osmotic stress [95], and a 
mutation that inactivates fimA presumably results in conservation of carbon and energy. 
The relationship between nagA, nagC, and surface fiber expression may also play a role 
in the fitness benefit of fimA inactivation, as the fimA insertions in A3 and A5 are 
associated with nag mutations as well. The inactivation of proV is more peculiar, given 
its extensively studied role in importing osmoprotectants into the cell [96]. Nonsense 
mutations affecting proV have been previously observed in osmotolerant mutants [76], 
providing additional evidence that proV is under negative selection in hyperosmotic 
glucose minimal medium. 
Mutations in several other genes, while not specifically known to affect osmotic 
tolerance, were also detected. G1 exhibited both a synonymous mutation in the cadB 
lysine transporter and an intergenic SNP between nmpC (an outer membrane protein 
associated with peptidoglycan) and essD, a holin for the integrated prophage DLP12. 
The latter gene has been shown to be important for cell wall maintenance and biofilm 
formation [97], which may explain the distinct mechanism behind G1’s osmotic 
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tolerance. G3 and G4 were found to have an 84-bp in-frame duplication (amino acids 
370 to 396) within the rpoC subunit of RNA polymerase. The duplications occur in 
region 2 of the protein, which is responsible for RNA polymerization [98]. Due to the 
role of rpoC in promoter recognition and sigma factor binding [99], this mutation should 
result in significant transcriptional and ultimately phenotypic alterations. Mutations in 
rpoC (along with rpoB) have been observed previously in other long-term evolution 
studies [87] as well, indicating that a wide range of phenotypes can be improved via 
alteration of RNA polymerase components. A small in-frame duplication was also 
observed in the essential but un- characterized hydrolase gene yejM, but the effect of this 
mutation is unclear. A range of SNPs in intergenic regions and the coding sequences of 
various other genes were also detected, including a synonymous substitution in treR, a 
negative regulator of trehalose biosynthesis, in G3 and the S6 ribosomal protein rpsA in 
G6. Other mutations of ribosomal proteins have been found to confer salt tolerance as 
well [100] by impairing ribosome maturation, but further investigation is needed to 
understand the functional consequences of this particular point mutation. 
In order to better understand the effect of these mutations on osmotolerance, we 
performed three tests to quantify the fitness effect of gene overexpression, 
compensation, and knockout on an unaltered host strain (BW25113) and the isolated 
evolved mutants. Eleven genes (nmpC, yobF, ydjK, mreB, fimA, nagC, nagA, proV, treR, 
ydhP, and cadB) were selected for overexpression studies due to their frequency of 
mutation or nearby intergenic or synonymous SNPs (results shown in Fig. 3A). Of all 
genes tested, only ydjK overexpression conferred a statistically significant improvement 
in osmotolerance. YdjK is annotated as a putative metabolite transporter, and due to the 
inclusion of tryptophan in the evolution medium, we reasoned that it might be an 
uncharacterized tryptophan transporter. However, YdjK did not confer a benefit in the 
absence of stress (P = 0.25, Student’s t test), so its true function remains unclear. 
Overexpression of proV, nagC, or nagA is also somewhat deleterious under these growth 
conditions, though fimA, which underwent transposon insertions in several independent 
mutants, did not have a significant effect on host fitness under these conditions. 
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Figure 3. Batch growth screening of overexpression, knockout, and compensatory strains 
to identify their osmotolerance phenotypes in glucose minimal medium supplemented 
with 0.55 M NaCl. (A) Fitness of overexpression strains relative to the empty vector 
pCA24N control. Only ydjK expression results in a significant tolerance improvement. 
(B) Fitness of knockout strains relative to BW25113; strain genotypes are denoted as 
follows: C, ΔNagC; A, ΔNagA; F, ΔFimA; and P, ΔProV. (C) Overexpression of NagC 
and NagA in mutants with possibly inactivating mutations in these genes; fitness is 
relative to the corresponding mutant with pCA24N. (D) Overexpression of FimA and 
ProV in mutants with possibly inactivating mutations in these genes, with the empty 
vector as a reference. All error bars are 95% confidence intervals based on the Student 
distribution [82]. 
Likely inactivating mutations in a small set of genes, including nagC, nagA, fimA, and 
proV, were identified in several of the G and A mutants. Various combinations of these 
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mutations were found in the evolved mutants, suggesting the presence of potential 
epistatic interactions that affect osmotic tolerance. We tested this hypothesis by 
systematically reconstructing double and triple mutants containing defined nagA or 
nagC disruptions, along with knockouts in fimA and proV. Figure 3B shows the relative 
fitness of these knockout mutants versus an unmodified BW25113 strain. Of the single 
mutants, only the proV strain is fitter than the reference. Interestingly, the nagA 
knockout has a large negative impact on strain fitness, suggesting that the insertion and 
deletion mutations identified in the sequenced mutants were not completely inactivating 
or the inactivation of nagA has a positive synergistic effect with other mutations in these 
mutants. As potential evidence for the presence of synergistic interactions between 
mutations, double knockouts of nagC and proV or nagA and fimA were found to be 
beneficial in the presence of NaCl challenge. Only the nagC fimA proV triple mutant 
showed improved osmotolerance relative to BW25113. These combinations did not 
occur in any mutant, and it is possible structural differences between the defined 
knockouts and mutations in the osmotolerant isolates could also influence these results. 
Overall, as was the case with overexpression analysis, these results indicate that these 
four genes affect the E. coli osmotolerance phenotype. 
An additional way of confirming that the mutations in nagA, nagC, proV, and fimA play 
a role in modulating osmotolerance is to complement the mutations in trans with an 
expression plasmid and then reassay their fitness under osmotic stress. The results of this 
test are shown in Fig. 3C and D and indicate that the effect of compensation depends 
heavily on the genetic background of the particular mutant. Relative fitness of only two 
nagC mutants (G5 and A4) out of five is decreased by nagC overexpression, while nagA 
complementation decreased osmotic tolerance of A1 to A3. The structure of the nagC 
mutations does vary significantly between the mutants, which may explain the lack of 
concordance in complementation results. Complementing the proV mutations in A3 and 
A4 had no significant fitness effect. While fimA overexpression decreased the fitness of 
A3, it also improved the fitness of A5 slightly, despite their identical IS186 insertions 
into the gene. It is likely that genetic differences between the various mutants and 
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interactions between other mutations not screened in this assay also play a significant 
role in determining the fitness impact of gene complementation.  
Though genome sequencing has revealed several novel loci involved with 
osmotolerance, the genotype-phenotype relationship remains unclear. To gain a more 
complete understanding of how these mutations translate into improved osmotic stress 
tolerance, we applied microarray technology to several A and G mutants with distinct 
underlying mutations to identify transcriptional perturbations that may result from their 
underlying mutations or altered stress responses. 
Mutation-induced transcriptional perturbations. Six sequenced mutants, G2, G3, G5, 
G6, A2, and A4, were selected for transcriptomic analysis based on their distinct 
underlying genotypes and varied levels of osmotolerance and therefore are likely to have 
diverse tolerance mechanisms. Genes commonly upregulated in these mutants, along 
with those representing possibly novel mechanisms, are listed in Table 2. The gene 
encoding AcrZ, a small protein associated with the AcrAB-TolC efflux pump complex 
known to affect AcrB substrate recognition [101], is upregulated in all mutants except 
A4, suggesting that it may be an important transcriptional adaptation. Sulfonate transport 
and metabolism genes (tauABC, ssuEADC) are also frequently upregulated in the 
mutants. Ordinarily, these proteins are intended to scavenge sulfur from the 
environment, but under osmotic stress, they can also import osmoprotectants such as 
taurine [102]. This upregulation cannot be explained as simple sulfur starvation, as the 
mutants and references were in exponential growth before RNA harvesting. The 
proVXW operon, positively regulated by hyperosmotic conditions [103], is also 
overexpressed by G3 and G5, though proX and proW are also overexpressed in A4, G3, 
G5, and G6. This expression pattern may explain the fitness benefit of proV deletion 
found in A3 and A4 in terms of energy conservation, as discussed previously. 
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Table 2. Overexpressed genes of interest [82]. 
 
Though the 2xOriT and Hfr-2xSFX− parental strains are for the most part isogenic, the 
latter is a tryptophan auxotroph due to insertion of the tra operon into the trp locus [77]. 
These four G strains all exhibited overexpression of the genes encoding the tryptophan 
transporter tnaB and tryptophanase tnaA, which converts tryptophan into indole and 
pyruvate, as has been previously observed in medium containing tryptophan [104]. 
Indole is a potent signaling molecule involved with various aspects of biofilm and cell 
cycle regulation [105], so the physiological effect of excess indole is likely to be 
complex. G2, G5, and G6 exhibit statistically significant increases (P < 0.05, Student’s t 
test) in indole accumulation compared to the Hfr-2xSFX− parent (Fig. 4) under osmotic 
stress. A4 produces significantly less indole (P <  0.045,Student’s t test) than its 2xOriT 
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ancestor as well. Despite the fact that G3 has roughly equivalent upregulation of tnaA 
transcription to these strains, indole production is similar to that of the wild type; it could 
be that the unusual in-frame duplication in rpoC in this strain results in increased tnaA 
transcription, but the resulting mRNA is poorly translated into protein or degraded 
rapidly due to posttranscriptional regulation. 
 
Figure  4. Levels of indole, normalized by biomass density, for G2, G3, G5, G6, A2, and 
A4 mutants, along with the G parent Hfr-2xSFX− and A parent 2xOriT. Error bars are 
standard deviations. G2, G5, and G6 (with asterisks) have statistically significant 
increases in indole accumulation compared to Hfr-2xSFX− (P < 0.05, Student's t test) 
[82]. 
Due to the intertwined nature of indole and biofilm regulation, we also examined the 
biofilm formation propensity of the evolved mutants. Most G and A mutants under 
osmotic stress form significantly less biofilm than their ancestral parents (Fig. 5), though 
G mutants typically had larger decreases than the A strains. Perturbations in the nag 
pathway may play a role in modulating biofilm formation, as both nagA and nagC 
deletions have been shown to affect surface fiber synthesis, including curli [106] and 
fimbriae [107], due to the accumulation of intracellular NAG-6-phosphate. Given the 
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large number of detected mutations that may affect biofilm formation or cell wall 
properties, this evolutionary route for tolerance improvement clearly warrants further 
research to better understand selection pressures on biofilm synthesis. 
 
Figure 5. Relative biofilm formation by G1 to G6 and A1 to A6 mutants in glucose 
minimal medium with 0.55 M (32 g/liter) NaCl. Data are ratios of mutant-specific 
biofilm formation to parental formation (G, Hfr-2xSFX−; A, 2xOriT) under these 
conditions. Data are normalized by biomass yield (OD600). Error bars are 95% 
confidence intervals [82]. 
Beyond metabolite transporters, several genes involved with iron uptake (entCEFH, 
feoB, fepG, fiu) were overexpressed in G3 and G5 as well. Increased expression of iron 
transport and metabolism genes has been found in evolved mutants with improved 
osmotic or n-butanol tolerance[62, 76]. Perturbation of iron metabolism may therefore 
be a contributor to osmotic tolerance, though the gene encoding the siderophore receptor 
fiu is also downregulated in G2 and G6. Genes involved in membrane composition were 
also upregulated in many mutants, particularly certain outer membrane porins 
(ompACGL) along with the ompX gene. These transcriptional disturbances may represent 
an attempt by the mutants to change membrane-sieving properties in order to reduce 
osmotic pressure on the cell. The peptidoglycan-outer membrane tether gene, lpp 
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(murein lipoprotein), was also overexpressed in four different mutants (A2, A4, G2, G3), 
which may indicate that the peptidoglycan wall is more strongly attached to the outer 
membrane in these mutants to protect the cell against high external osmotic pressure. 
Several genes that encode hypothetical or predicted proteins (ydcH, yodC) are 
consistently overexpressed in the G mutants, but no information about their biochemical 
roles or relationship with osmotolerance is known. 
In contrast to the relative similarities in gene overexpression under osmotic stress 
between these six mutants, less similarity is observed for genes repressed relative to the 
parental references (Table 3). The few commonly repressed genes include those coding 
for several hypothetical or conserved proteins (yegR, ydeMN, rtcB) and the 
transcriptional activator ydeO, known to regulate acid resistance in concert with EvgA 
[108]. Their repression may be associated with the reduced osmotic stress experienced 
by the mutants compared to that of their parents under these conditions, as these genes 
are not known to be directly regulated by osmotic stress. Downregulation of several 
siderophores and enterobactin transporters was observed in G2, G5, and G6, including 
fepA, which was found to be strongly overexpressed in a previously evolved 
osmotolerant E. coli strain [76]. 
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Table 3. Repressed genes of interest [82]. 
 
As was the case for upregulated genes, repression of genes involved with peptidoglycan 
and membrane biosynthesis was significantly enriched in the mutant transcriptomes 
according to gene ontology analysis. NAG catabolism genes, nagA, nagB, and nagE, 
were repressed in A4 and several G mutants. Repression of many other peptidoglycan or 
outer membrane-related genes was observed in A2 and A4, particularly those genes 
involved with cell wall maturation (mltD, murC) or lipopolysaccharide synthesis (rfaZ, 
kdsB, wbbK). Membrane remodeling therefore appears to be a significant adaptive 
response in these mutants. Fimbriae synthesis and assembly genes were also repressed in 
G5 and G6, lending credence to the hypothesis that fimA inactivation may be part of an 
energy conservation response during laboratory evolution. Porin synthesis also is 
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perturbed in G3 and G6 by simultaneous repression of ompF and overexpression of 
ompC, as is typically observed under high osmotic pressure [109]. The totality of these 
transcriptional responses point to wide-ranging changes in gene expression affecting 
membrane composition, transport activity, iron metabolism, and other systems stemming 
from various underlying genetic changes, to alleviate osmotic stress in these mutants. 
Comparison of sexual, asexual adaptation. Evolving populations are generally 
genetically heterogeneous and therefore contain competing mutant lineages that have 
arisen independently. Clonal interference will generally reduce this diversity, possibly 
resulting in a more narrow distribution of mutant fitnesses within asexual populations. 
To test this hypothesis, we isolated random clones from the Hfr-2xSFX− and 2xOriT 
populations to evaluate the degree of fitness heterogeneity within each population and to 
determine whether horizontal gene transfer had a detectable effect on the population 
structure. The fitness distributions for these populations, shown in Fig. 6, show that Hfr-
2xSFX− lines tended to have a slightly higher mean relative fitness but with significantly 
more variance than the 2xOriT replicates at a high level of significance (P =1.81 X10-4, 
Kolmogorov-Smirnov test). Genetic diversity within Hfr-2xSFX− lines may therefore be 
greater than that of the 2xOriT populations; a likely explanation is that horizontal gene 
transfer reduces the extinction of beneficial clones due to clonal interference and drift, 
resulting in a maintenance of heterogeneity that is less likely to occur in an asexual 
population [110, 111]. However, as all populations reached similar fitness endpoints 
during the experiment, further adaptation beyond that observed here could be mutation 
limited.  
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Figure 6. Histogram of relative fitness (to 2xOriT) in randomly screened isolates from 
six Hfr-2xSFX− (A) and 2xOriT (B) populations. All isolates were challenged with 0.65 
M (38 g/liter) NaCl. Differences in the underlying fitness distributions in the Hfr-
2xSFX− and 2xOriT populations are highly significant (P = 1.81 × 10−4, Kolmogorov-
Smirnov test) [82]. 
In an attempt to further improve the observed NaCl tolerance levels of the mutants, we 
performed a short-term mating experiment where the G1 to G6 isolates were mixed 
together to facilitate genetic transfer and then propagated under NaCl selection for 5 
days. Surprisingly, analysis of clonal isolates from the mixed G population revealed that 
the fittest clones were no better than the original fittest Hfr-2xSFX− mutant G6 (data not 
shown). Genome sequencing revealed that many of the G mutants have mutations in 
close proximity or actually overlapping in the case of the independent nagC mutations. 
Recombination events capable of combining these genotypes may therefore be rare. 
Negative epistasis between other mutations may have also prevented successful 
generation of recombinants. 
Conclusions. These results provide new insight into the E. coli osmotolerance 
phenotype. All isolates exhibited high levels of osmotolerance as expected, and a 
surprising lack of cross-adaptation to other stressors, such as excess glucose, n-butanol, 
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low pH, and thermal stress. Genomic sequencing revealed novel mutations in genes 
related to n-acetylglucosamine catabolism, cell shape regulation, uptake of 
osmoprotectants, and global regulators such as rpoC. Many of the mutations occurred in 
genes known to affect cell wall or peptidoglycan maintenance. On a transcriptional level, 
membrane and peptidoglycan synthesis, porin expression, sulfonate uptake, and iron 
metabolism are all significantly perturbed in various evolved mutants relative to their 
parental references and might be targets of interest for future studies of this phenotype. 
Future work will continue to explore the transcriptomic data in hopes of identifying 
additional loci influencing osmotic tolerance, in addition to reconstructing the observed 
mutations in the A and G isolates in industrial E. coli strains to improve their 
osmotolerance under industrial conditions. 
 
 
 
 
 
 
 
  
 
 
 
  
 
 
 
   
